Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Pediatrics | Research | News

Back to Health News

Research Highlights Genetic Risk for Autism

Last Updated: April 28, 2009.

 

Expert calls new findings a 'crack in the facade' of the disorder

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Expert calls new findings a 'crack in the facade' of the disorder.

By Alan Mozes
HealthDay Reporter

TUESDAY, April 28 (HealthDay News) -- Inheriting abnormal mutations of two common genes can raise the risk for developing autism, according to one of two new studies highlighting the complex genetic roots of the disorder.

Both genes are located in the brain's frontal lobe region, responsible for complex social behavior and abstract thought, and are normally involved in the proper functioning of healthy brain cell connections. Both also play a key role in the formation of those connections, or synapses, which allow brain cells to communicate and enable learning, cognition, and memory.

The second study found that the risk for autism may rise in rare instances when normal DNA variations disturb genes along a particular neural pathway, one linked to smooth nervous system development and synapse function.

"By using state-of-the-art technology and large samples, we discovered new genes that appear to increase susceptibility to autism," said Geraldine Dawson, a co-author of both studies and the chief science officer of Autism Speaks, an international funder and advocate for biomedical autism research.

"The main point," she said, "is that these genes appear to act in conjunction with other genes -- some of which are identified already, but most of which are not yet identified -- to impact on the way synapses, or brain cell connections, are made."

"And the other point is that the genes that were found are associated with a specific pathway in the brain," Dawson said. "And this is important in that we might eventually be able to begin to develop treatments to target this specific biochemical pathway."

Dawson worked in collaboration with Dr. Hakon Hakonarson, director of the Center for Applied Genomics at the Children's Hospital of Philadelphia and the study's leader; Gerard D. Schellenberg, a professor of pathology and laboratory medicine at the University of Pennsylvania; and Kai Wong, also at Children's Hospital.

Hakonarson, Schellenberg and Wong presented the findings Tuesday during a London-based teleconference. They are published online today in Nature.

"This is the first crack in the facade of this disease," according to Schellenberg. He said the findings represent "the next step in understanding the fundamental molecular biology of what's happening in autism."

"And this really gets us a major jump, we think, in terms of knowing what targets to look at," he said, referring to the development of therapies to combat both the risk for and onset of autism.

For the first study, the researchers conducted a genetic analysis of more than 10,000 children, of whom 4,500 had a diagnosis of autism spectrum disorder, a grouping of neural developmental problems involving verbal skills as well as social interaction and behavior.

The effort yielded two autism-associated culprits -- variants of the CDH10 and CDH9 genes -- which the researchers suggested could underlie the risk for autism in about 15 percent of cases.

For the second study, researchers looked specifically at the genetic "roadmap" of children with autism spectrum disorder and isolated two genes along the so-called "ubiquitin pathway" -- the UBE3A and PARK2 genes-- that appeared vulnerable to deletion/replication variations. The variations seemed to undermine the genes' ability to ensure smooth cell communication across brain synapses. That study involved 859 children with an autism spectrum disorder and more than 1,400 children without such disorders.

Collectively, these findings emphasize the complexity of the genetic underpinnings of autism, the researchers said. And they stressed that having these genetic predispositions does not necessarily mean a higher risk for the disorder in the absence of other critical factors.

"We think that, in most cases, autism is caused by a combination of several genes, and they may interact with environmental factors that we have not yet identified," Dawson said. "So you could think about it as you would the risk for a heart attack. If you have high cholesterol alone and you go to your doctor, he may not be too worried. But if you have several risk factors -- high cholesterol plus high blood pressure -- the risk for getting the disease is much higher."

"So these are one of a set of genes associated with autism risk," she said. "And if you inherit the whole set, you would have a higher risk for developing the disease. But you can have these particular genes and not have a higher risk for autism."

Despite that, the findings still hold much to be excited about.

"Even though there appear to be many different genes involved in autism, what is very interesting is that the genes we're finding are clustering around the same brain function -- namely, the connections between brain cells," she said. "This is important because, when we learn new things or form memories or learn new skills, we do this by creating new connections between cells. So if there is a problem doing this, then this will affect our ability to engage in complex behaviors and learn new skills. And this could explain why people with autism have cognitive delay and have such difficulty learning new things."

"So we're getting a better picture now of what contributes to autism," Dawson said.

More information

The Autism Society of America has more on autism.

SOURCES: Geraldine Dawson, Ph.D., chief science officer, Autism Speaks, New York City; teleconference, April 28, 2009, with Hakon Hakonarson, M.D., Ph.D., director, Center for Applied Genomics, Children's Hospital of Philadelphia, Gerard D. Schellenberg, Ph.D., professor, pathology and laboratory medicine, University of Pennsylvania, and Kai Wong, Ph.D., Children's Hospital of Philadelphia; April 28, 2009, Nature, online

Copyright © 2009 ScoutNews, LLC. All rights reserved.


Previous: Acrylamide Doesn't Raise Lung Cancer Risk Next: Tysabri May Treat Myelin Sheath Damage From MS

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.